XML 19 R9.htm IDEA: XBRL DOCUMENT
v3.23.3

Fair Value Measurements | 9 Months Ended
--- | ---
Sep. 30, 2023
Fair Value Disclosures [Abstract] |
Fair Value Measurements | Fair Value Measurements Financial Assets The following tables provide the financial assets measured at fair value on a recurring basis:
|  | Amortized Cost or Carrying Value |  | Gross Unrealized Gains |  | Gross Unrealized Losses Less Than 12 Months |  | Gross Unrealized Losses More Than 12 Months |  | Fair Value Hierarchy as of September 30, 2023 |  | Aggregate Fair Value
|  | Level 1 |  | Level 2 |  | Level 3
Financial Assets: |  | (In thousands)
Cash and cash equivalents: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Money market funds |  | $ | 418,098 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 418,098 |  |  | $ | — |  |  | $ | — |  |  | $ | 418,098 |
Commercial paper |  | 23,311 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 23,311 |  |  | — |  |  | 23,311 |
Total included in cash and cash equivalents |  | 441,409 |  |  | — |  |  | — |  |  | — |  |  | 418,098 |  |  | 23,311 |  |  | — |  |  | 441,409 |
Marketable securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Debt securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
U.S. Treasury securities |  | 528,950 |  |  | 20 |  |  | (1,060) |  |  | (3,999) |  |  | 523,911 |  |  | — |  |  | — |  |  | 523,911 |
Non-U.S. government securities |  | 115,923 |  |  | — |  |  | — |  |  | (2,897) |  |  | 113,026 |  |  | — |  |  | — |  |  | 113,026 |
Corporate debt securities and commercial paper |  | 2,577,183 |  |  | 134 |  |  | (9,810) |  |  | (31,002) |  |  | 16,690 |  |  | 2,519,815 |  |  | — |  |  | 2,536,505 |
Total debt securities |  | 3,222,056 |  |  | 154 |  |  | (10,870) |  |  | (37,898) |  |  | 653,627 |  |  | 2,519,815 |  |  | — |  |  | 3,173,442 |
Equity securities |  | 6,050 |  |  | — |  |  | — |  |  | — |  |  | 6,050 |  |  | — |  |  | — |  |  | 6,050 |
Total marketable securities |  | 3,228,106 |  |  | 154 |  |  | (10,870) |  |  | (37,898) |  |  | 659,677 |  |  | 2,519,815 |  |  | — |  |  | 3,179,492 |
Total financial assets |  | $ | 3,669,515 |  |  | $ | 154 |  |  | $ | (10,870) |  |  | $ | (37,898) |  |  | $ | 1,077,775 |  |  | $ | 2,543,126 |  |  | $ | — |  |  | $ | 3,620,901 |
|  | Amortized Cost or Carrying Value |  | Gross Unrealized Gains |  | Gross Unrealized Losses Less Than 12 Months |  | Gross Unrealized Losses More Than 12 Months |  |  |  | Fair Value Hierarchy as of December 31, 2022 |  | Aggregate Fair Value
|  |  | Level 1 |  | Level 2 |  | Level 3
Financial Assets: |  | (In thousands)
Cash and cash equivalents: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Money market funds |  | $ | 46,610 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  |  |  | $ | 46,610 |  |  | $ | — |  |  | $ | — |  |  | $ | 46,610 |
Reverse repurchase agreements |  | 200,000 |  |  | — |  |  | — |  |  | — |  |  |  |  | — |  |  | 200,000 |  |  | — |  |  | 200,000 |
Commercial paper |  | 2,249 |  |  | — |  |  | — |  |  | — |  |  |  |  |  |  | 2,249 |  |  |  |  | 2,249 |
Total included in cash and cash equivalents |  | 248,859 |  |  | — |  |  | — |  |  | — |  |  |  |  | 46,610 |  |  | 202,249 |  |  | — |  |  | 248,859 |
Marketable securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
U.S. Treasury securities |  | 481,463 |  |  | — |  |  | (1,269) |  |  | (11,347) |  |  |  |  | 468,847 |  |  | — |  |  | — |  |  | 468,847 |
Non-U.S. government securities |  | 149,901 |  |  | — |  |  | (33) |  |  | (6,304) |  |  |  |  | 143,564 |  |  | — |  |  | — |  |  | 143,564 |
Corporate debt securities and commercial paper |  | 2,973,844 |  |  | 307 |  |  | (12,202) |  |  | (71,043) |  |  |  |  | 5,000 |  |  | 2,885,906 |  |  | — |  |  | 2,890,906 |
Total marketable securities |  | 3,605,208 |  |  | 307 |  |  | (13,504) |  |  | (88,694) |  |  |  |  | 617,411 |  |  | 2,885,906 |  |  | — |  |  | 3,503,317 |
Total financial assets |  | $ | 3,854,067 |  |  | $ | 307 |  |  | $ | (13,504) |  |  | $ | (88,694) |  |  |  |  | $ | 664,021 |  |  | $ | 3,088,155 |  |  | $ | — |  |  | $ | 3,752,176 |
Debt Securities The aggregate fair value of the corporate debt securities with unrealized losses was $2.3 billion as of September 30, 2023, of which $1.2 billion were in an unrealized loss position for more than 12 months and $1.1 billion were in an unrealized loss position for less than 12 months. The aggregate fair value of corporate debt securities with unrealized losses was $2.7 billion as of December 31, 2022, of which $2.0 billion were in an unrealized loss position for more than 12 months and $620.5 million were in an unrealized loss position for less than 12 months. Unrealized losses related to other investments as of September 30, 2023 and December 31, 2022 were not significant. The Company’s primary objective when investing excess cash is preservation of capital, hence the Company’s debt securities primarily consist of U.S. Treasury Securities, non-U.S government securities, high credit quality corporate debt securities and commercial paper. Because the Company views its debt securities as available to support current operations, it has classified all available for sale securities as short-term. As of September 30, 2023, and December 31, 2022, for all debt securities that were in unrealized loss positions, the Company has determined that (i) it does not have the intent to sell any of these investments, and (ii) it is not more likely than not that it will be required to sell any of these investments before recovery of the entire amortized cost basis. In addition, as of September 30, 2023 and December 31, 2022, the Company anticipates that it will recover the entire amortized cost basis of such debt securities before maturity. Interest earned on debt securities was $19.3 million and $53.2 million in the three and nine months ended September 30, 2023, respectively, and $16.3 million and $47.5 million in the three and nine months ended September 30, 2022, respectively. The interest is recorded as other income (expenses), net, in the accompanying condensed consolidated statements of operations. The following table summarizes the contractual maturities of debt securities:
|  | As of September 30, |  | As of December 31,
|  | 2023 |  | 2022
|  | Amortized Cost |  | Aggregate Fair Value |  | Amortized Cost |  | Aggregate Fair Value
Financial Assets: |  | (In thousands)
Less than one year |  | $ | 1,740,368 |  |  | $ | 1,710,876 |  |  | $ | 1,943,836 |  |  | $ | 1,909,218 |
One to three years |  | 1,481,688 |  |  | 1,462,566 |  |  | 1,661,372 |  |  | 1,594,099 |
Total |  | $ | 3,222,056 |  |  | $ | 3,173,442 |  |  | $ | 3,605,208 |  |  | $ | 3,503,317 |
Equity Securities The equity securities consist of shares of a publicly traded company that were received as consideration in a divestiture transaction described further in Note 5. Strategic Investments As of September 30, 2023 and December 31, 2022, the Company held strategic investments with a carrying value of $30.7 million and $76.9 million, respectively, recorded as other long-term assets in the accompanying condensed consolidated balance sheets. The carrying value of these securities is determined under the measurement alternative on a non-recurring basis and adjusted for observable changes in fair value or impairment. In the nine months ended September 30, 2023, the Company remeasured to fair value one of its strategic investments acquired in 2021 due to an assessed impairment. The fair value measurement of the strategic investment is classified as Level 2 in the fair value hierarchy and the primary input used in the fair value measurement was the publicly available stock price of the issuer’s unrestricted security of the same class. The impairment loss of $46.2 million is recorded in other expenses, net, in the accompanying condensed consolidated statement of operations for the nine months ended September 30, 2023. There were no other impairments or adjustments recorded in the three and nine months ended September 30, 2023 and 2022 related to these securities. Financial Liabilities The Company’s financial liabilities that are measured at fair value on a recurring basis consist of foreign currency derivative liabilities and are classified as Level 2 financial instruments in the fair value hierarchy. As of September 30, 2023 and December 31, 2022, the aggregate fair value of these liabilities and the associated unrealized losses were not significant. The Company’s financial liabilities that are not measured at fair value on a recurring basis are its Senior Notes due 2029 (“2029 Notes”) and its Senior Notes due 2031 (“2031 Notes”). As of September 30, 2023, the fair value of the 2029 Notes and 2031 Notes were $419.0 million and $407.5 million, respectively. As of December 31, 2022, the fair value of the 2029 Notes and 2031 Notes were $410.9 million and $399.4 million, respectively.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration